Clinical Study of BRL-101 in Severe SCD

Clinical trial NCT06300723 · UNKNOWN

Trial details

NCT number: NCT06300723
Sponsor: Bioray Laboratories
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2024-07-29
Primary completion: 2026-03-20
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.